Register entry

Vertex Pharmaceuticals Incorporated

Registered sites
1
Drug products
21
Live patents
601
Countries
1
Base
United States
Authorisation

Registered operations

What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.

Analytical testingFinished drug manufacture
Sites

Facilities

1
SiteLocationOperationsFEI
Vertex Pharmaceuticals IncorporatedBoston, MAUnited StatesAnalytical testing, Finished drug manufacture1000513211
Exclusivity

Patents

601

Unexpired Orange Book patents where this company is the application holder.

ProductActive ingredientExpiry
ALYFTREKDEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUMDec 2026
ALYFTREKDEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUMApr 2027
ALYFTREKDEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUMMay 2027
ALYFTREKDEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUMMay 2027
ALYFTREKDEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUMJun 2027
ALYFTREKDEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUMAug 2027
ALYFTREKDEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUMNov 2027
ALYFTREKDEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUMAug 2029
ALYFTREKDEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUMMar 2031
ALYFTREKDEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUMJul 2031
ALYFTREKDEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUMMay 2032
ALYFTREKDEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUMJul 2033
ALYFTREKDEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUMApr 2035
ALYFTREKDEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUMFeb 2039
ALYFTREKDEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUMAug 2040
ALYFTREKDEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUMJan 2043
INCIVEKTELAPREVIRMay 2028
JOURNAVXSUZETRIGINEDec 2040
KALYDECOIVACAFTORDec 2026
KALYDECOIVACAFTORJan 2027
KALYDECOIVACAFTORMay 2027
KALYDECOIVACAFTORJun 2027
KALYDECOIVACAFTORAug 2027
KALYDECOIVACAFTORNov 2027
KALYDECOIVACAFTORFeb 2028
KALYDECOIVACAFTORAug 2029
KALYDECOIVACAFTORFeb 2030
KALYDECOIVACAFTORFeb 2033
KALYDECOIVACAFTORAug 2033
ORKAMBIIVACAFTOR; LUMACAFTORNov 2026
ORKAMBIIVACAFTOR; LUMACAFTORDec 2026
ORKAMBIIVACAFTOR; LUMACAFTORMay 2027
ORKAMBIIVACAFTOR; LUMACAFTORMay 2027
ORKAMBIIVACAFTOR; LUMACAFTORJun 2027
ORKAMBIIVACAFTOR; LUMACAFTORAug 2027
ORKAMBIIVACAFTOR; LUMACAFTORNov 2027
ORKAMBIIVACAFTOR; LUMACAFTORFeb 2028
ORKAMBIIVACAFTOR; LUMACAFTORDec 2028
ORKAMBIIVACAFTOR; LUMACAFTORJun 2029
ORKAMBIIVACAFTOR; LUMACAFTORJul 2029
ORKAMBIIVACAFTOR; LUMACAFTORAug 2029
ORKAMBIIVACAFTOR; LUMACAFTORSept 2029
ORKAMBIIVACAFTOR; LUMACAFTORJan 2030
ORKAMBIIVACAFTOR; LUMACAFTORFeb 2030
ORKAMBIIVACAFTOR; LUMACAFTORMar 2030
ORKAMBIIVACAFTOR; LUMACAFTORSept 2030
ORKAMBIIVACAFTOR; LUMACAFTORDec 2030
ORKAMBIIVACAFTOR; LUMACAFTORMar 2031
ORKAMBIIVACAFTOR; LUMACAFTORJun 2031
SYMDEKO (COPACKAGED)IVACAFTOR; IVACAFTOR, TEZACAFTORDec 2026
SYMDEKO (COPACKAGED)IVACAFTOR; IVACAFTOR, TEZACAFTORApr 2027
SYMDEKO (COPACKAGED)IVACAFTOR; IVACAFTOR, TEZACAFTORMay 2027
SYMDEKO (COPACKAGED)IVACAFTOR; IVACAFTOR, TEZACAFTORMay 2027
SYMDEKO (COPACKAGED)IVACAFTOR; IVACAFTOR, TEZACAFTORJun 2027
SYMDEKO (COPACKAGED)IVACAFTOR; IVACAFTOR, TEZACAFTORAug 2027
SYMDEKO (COPACKAGED)IVACAFTOR; IVACAFTOR, TEZACAFTORNov 2027
SYMDEKO (COPACKAGED)IVACAFTOR; IVACAFTOR, TEZACAFTORAug 2029
SYMDEKO (COPACKAGED)IVACAFTOR; IVACAFTOR, TEZACAFTORMar 2031
SYMDEKO (COPACKAGED)IVACAFTOR; IVACAFTOR, TEZACAFTORJul 2031
SYMDEKO (COPACKAGED)IVACAFTOR; IVACAFTOR, TEZACAFTORJul 2033
Catalogue

Marketed products

21

Showing 21 of 21.

BrandGeneric nameFormCategory
ALYFTREKvanzacaftor, tezacaftor, and deutivacaftorTABLET, FILM COATEDNDA
ALYFTREKvanzacaftor, tezacaftor, and deutivacaftorTABLET, FILM COATEDNDA
CASGEVYexagamglogene autotemcelINJECTION, SUSPENSIONBLA
JOURNAVXSuzetrigineTABLET, FILM COATEDNDA
KalydecoivacaftorTABLET, FILM COATEDNDA
KalydecoivacaftorGRANULENDA
KalydecoivacaftorGRANULENDA
KalydecoivacaftorGRANULENDA
KalydecoivacaftorGRANULENDA
KalydecoivacaftorGRANULENDA
ORKAMBIlumacaftor and ivacaftorGRANULENDA
ORKAMBIlumacaftor and ivacaftorGRANULENDA
ORKAMBIlumacaftor and ivacaftorTABLET, FILM COATEDNDA
ORKAMBIlumacaftor and ivacaftorTABLET, FILM COATEDNDA
ORKAMBIlumacaftor and ivacaftorGRANULENDA
SYMDEKOTezacaftor and IvacaftorKITNDA
SYMDEKOTezacaftor and IvacaftorKITNDA
TrikaftaElexacaftor, Tezacaftor, and IvacaftorKITNDA
TrikaftaElexacaftor, Tezacaftor, and IvacaftorKITNDA
TrikaftaElexacaftor, Tezacaftor, and IvacaftorKITNDA
TrikaftaElexacaftor, Tezacaftor, and IvacaftorKITNDA
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.